Drug Trial Radar · NCT06405633
A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
48
Planned (sponsor's estimate)
Start
Jul 19, 2024
Primary completion
Sep 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Wave Life Sciences USA, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 8, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this open-label study is to assess the safety, tolerability, pharmacodynamics, and pharmacokinetics of WVE-006 in participants with alpha-1 antitrypsin deficiency (AATD) following Period 1 single ascending dose (SAD) and Period 2 multiple ascending doses (MAD), respectively.
Conditions
- Alpha-1 Antitrypsin Deficiency
Interventions
WVE-006Drug
RNA editing oligonucleotide
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of participants with adverse eventsTime frame: Up to 36 Weeks
Locations
9 sites in 6 countries. Site status is shown where the registry gives one.
St. Vincent's Hospital, Melbourne
Fitzroy, Victoria, Australia · Recruiting
Dalhousie University - Queen Elizabeth II Health Sciences Centre
Halifax, Nova Scotia, Canada · Recruiting
Inspiration Research Limited
Toronto, Ontario, Canada · Recruiting
Turku University Hospital
Turku, Finland · Active not recruiting
Universitaetsklinikum Aachen, AoeR
Aachen, Germany · Active not recruiting
Waikato Hospital
Hamilton, New Zealand · Recruiting
Queen Elizabeth Hospital, University Hospital Birmingham
Birmingham, United Kingdom · Active not recruiting
Cambridge University - Addenbrooke's Hospital
Cambridge, United Kingdom · Active not recruiting
Royal Free London NHS Foundation Trust
London, United Kingdom · Active not recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.